Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tamatinib |
Trade Name | |
Synonyms | R406|R-406 |
Drug Descriptions |
Tamatinib (R406) inhibits SYK, resulting in decreased downstream signaling and and potentially leading to reduced tumor cell proliferation and viability (PMID: 16946104, PMID: 26251761, PMID: 30668583). |
DrugClasses | SYK Inhibitor 15 |
CAS Registry Number | 841290-80-0 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
A-770041 + Tamatinib | A-770041 Tamatinib | 0 | 0 |
Pictilisib + Tamatinib | Pictilisib Tamatinib | 0 | 0 |
Tamatinib | Tamatinib | 5 | 0 |
Tamatinib + Tazemetostat | Tamatinib Tazemetostat | 0 | 0 |
Tamatinib + Trametinib | Tamatinib Trametinib | 0 | 0 |